SGLT2 inhibitors: A groundbreaking class of cardiovascular drugs, but who benefits most?

被引：0
|
作者：
Koufakis, Theocharis [1 ]
Popovic, Djordje S. [2 ,3 ]
Maltese, Giuseppe [4 ,5 ]
Papanas, Nikolaos [6 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokration Gen Hosp, Propedeut Dept Internal Med 2, Thessaloniki 54642, Greece
[2] Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[3] Univ Novi Sad, Med Fac, Novi Sad, Serbia
[4] Epsom & St Helier Univ Hosp, Dept Diabet & Endocrinol, Sutton SM5 1AA, Surrey, England
[5] Kings Coll London, Fac Life Sci & Med, Cardiovasc Div, Unit Metab Med, London WC2R 2LS, England
[6] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Diabet Ctr, Dept Internal Med 2, Alexandroupolis, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2024年 / 412卷
关键词：
SGLT2; inhibitors; Heart failure; Myocardial infarction; Nt-proBNP;
D O I：
10.1016/j.ijcard.2024.132326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Investigating Cardiovascular Benefits of SGLT2 Inhibitors
    Sieracki, Lauren
    Sordi, Christina
    Ostroff, Marissa L.
    Ostroff, Jared L.
    US PHARMACIST, 2022, 47 (11) : 17 - 22
  • [2] A review of cardiovascular benefits of SGLT2 inhibitors
    Zhang, Yingxia
    Han, Qinghua
    MEDICINE, 2022, 101 (36) : E30310
  • [3] Possible mechanisms of cardiovascular benefits of SGLT2 inhibitors
    Verges, B.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2019, 11 : S18 - S22
  • [4] Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
    Rabizadeh, Soghra
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 17 (02)
  • [5] The SGLT2 inhibitors: a new class of oral antidiabetic drugs
    不详
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2014, 18 (4-5): : 10 - 13
  • [6] Promising cardiovascular and blood pressure effects of the SGLT2 inhibitors: a new class of antidiabetic drugs
    Chrysant, S. G.
    DRUGS OF TODAY, 2017, 53 (03) : 191 - 202
  • [7] Benefits of SGLT2 inhibitors in arrhythmias
    Gao, Jinghan
    Xue, Genlong
    Zhan, Ge
    Wang, Xinying
    Li, Jiatian
    Yang, Xiaolei
    Xia, Yunlong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
    Preda, Alberto
    Montecucco, Fabrizio
    Carbone, Federico
    Camici, Giovanni G.
    Luscher, Thomas F.
    Kraler, Simon
    Liberale, Luca
    CARDIOVASCULAR RESEARCH, 2024, 120 (05) : 443 - 460
  • [9] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [10] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Rohit Singhal
    Lisa Aimee Hechanova
    Current Cardiology Reports, 2022, 24 : 183 - 189
12345